Showing results (1-10 of 5,037) with videos related to

Sort By:
Pageof 504
Multiple Sclerosis and Related Disorders|March 13, 2021
"Peppering the pons": CLIPPERS or myelin oligodendrocyte glycoprotein associated disease?Ahmed Z Obeidat, Allison N Block, Sam I Hooshmand
Multiple Sclerosis and Related Disorders|March 19, 2021
Willingness to be vaccinated against COVID-19: An exploratory online survey in a Portuguese cohort of multiple sclerosis patientsFilipa Serrazina, André Sobral Pinho, Gonçalo Cabral, et al.
Multiple Sclerosis and Related Disorders|December 2, 2021
Do Pilates exercises improve balance in patients with multiple sclerosis? A systematic review and meta-analysisMeltem Isintas Arik, Humeyra Kiloatar, Ismail Saracoglu
Multiple Sclerosis and Related Disorders|December 4, 2021
Recognizing visual complaints in people with multiple sclerosis: Prevalence, nature and associations with key characteristics of MSF E van der Feen, G A de Haan, I van der Lijn, et al.
Multiple Sclerosis and Related Disorders|December 3, 2021
Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosisMasaaki Niino, Shoko Fukumoto, Tatsusada Okuno, et al.
Multiple Sclerosis and Related Disorders|February 17, 2019
Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disordersLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Multiple Sclerosis and Related Disorders|February 17, 2019
Barriers against a successful MS treatment: The importance of effectiveness beyond efficacyRicardo Alonso, Edgar Carnero Contentti, Gaston Imhoff, et al.
Multiple Sclerosis and Related Disorders|February 20, 2019
Isolated recurrent myelitis in a persistent MOG positive patientS Anis, K Regev, S J Pittock, et al.
Multiple Sclerosis and Related Disorders|March 9, 2019
Efficacy and safety of alemtuzumab in Korean multiple sclerosis patientsHyunjin Kim, Eun-Jae Lee, Sung Keun Kim, et al.
Multiple Sclerosis and Related Disorders|March 10, 2019
Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60Le H Hua, Haleigh Harris, Devon Conway, et al.
Pageof 504